X-Vax rakes in $56 mln
Jupiter, Florida-based X-Vax Technology Inc, a herpes vaccines developer, has raised $56 million in funding. The investors included Johnson & Johnson Innovation – JJDC, Inc., Adjuvant Capital, Serum Institute of India, Alexandria Venture Investments and FF DSF VI.</strong
23 July 2019•1 min read
